Delivery Order SPE2DR25D9127-SPE2DR26FCZE2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $61,096.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 3,750 units of Asparlas (5 ML vials). This firm fixed-price delivery order, issued on November 13, 2025, with an ultimate completion date of December 5, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 3,750 units of Asparlas (5 mL vials) with a ceiling value of $20,365.58. This firm fixed-price delivery order, issued on November 24, 2025, will be performed in Park Ridge and is scheduled for completion by December 16, 2025. The award was made without a set-aside designation, demonstrating DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a delivery order valued at $81,462.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of 3,750 units of Asparlas (5 ML vials). The contract is firm fixed-price with no set-aside designation and carries an ultimate completion date of January 15, 2026. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $148,084.30 by the Defense Logistics Agency on September 26, 2025, for the supply of 3,750 units of Asparlas (5 milliliter vials). The award carries a firm fixed-price structure with an ultimate completion date of October 20, 2025, and represents no set-aside designation. The place of performance is located in Park Ridge, Illinois, where...
- The Defense Logistics Agency awarded a delivery order valued at $148,084.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 3,750 units of Asparlas 5 milliliter vials. This firm fixed-price delivery order is expected to reach completion by August 29, 2025, and represents a continuation of the companies' ongoing pharmaceutical supply relationship. The award carries no set-aside designation, indicating that DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $59,233.74 by the Defense Logistics Agency on September 10, 2025. The delivery order, with an ultimate completion date of October 1, 2025, calls for the supply of 3,750 units of Asparlas in 5 milliliter vials. This award was issued without a set-aside designation and represents a specific product delivery under DMS...
- The Defense Logistics Agency awarded a $148,084.30 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on July 17, 2025. The delivery order calls for 3,750 units of Asparlas (5 ML vials) with a completion date of August 7, 2025. This firm fixed-price contract contains no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market despite its small business status. The award...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,850.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 19, 2025, represents one of numerous orders placed under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative....
- The Defense Logistics Agency awarded a $99,504.78 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, was awarded without a set-aside designation. DMS Pharmaceutical Group is the sole awardee with no identified subcontractors on this action. The delivery order falls under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 3,750 units of Asparlas 5 mL vials. The contract, valued at $59,233.74, is structured as a firm fixed-price delivery order with an ultimate completion date of August 22, 2025. This award was issued without set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal...
- SPE2DR25D9127Indefinite Delivery Contract
- SPE2DR25D9127-SPE2DR26FCZE2Delivery Order
The Defense Logistics Agency has issued a delivery order valued at $85,262.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 3,750 units of Asparlas (5 mL vials). This firm fixed-price delivery order, awarded on January 7, 2026, is expected to be completed by January 29, 2026. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. is the sole awardee with no identified subcontractors involved in this transaction. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, designated SPE2DR, which was awarded under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. That master contract, valued at $499,999,999 with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy designed to supply pharmaceutical products and medical consumables to military healthcare facilities worldwide. The company's registration in the System for Award Management since 2001 and demonstrated performance across multiple therapeutic categories reflect its established role as a critical supplier within the Department of Defense pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $85.3k | 1/6/26 |